Recommended Conferences

Parkinsons Congress 2022

London, UK

Psychology Health 2022

Amsterdam, Netherlands
 

Neurobiology of alcohol dependence: focus on motivational mechanisms

Author(s): Gilpin NW, Koob GF

Abstract

Alcoholism is a debilitating disorder for the individual and very costly for society. A major goal of alcohol research is to understand the neural underpinnings associated with the transition from alcohol use to alcohol dependence. Positive reinforcement is important in the early stages of alcohol use and abuse. Negative reinforcement can be important early in alcohol use by people self-medicating coexisting affective disorders, but its role likely increases following the transition to dependence. Chronic exposure to alcohol induces changes in neural circuits that control motivational processes, including arousal, reward, and stress. These changes affect systems utilizing the signaling molecules dopamine, opioid peptides, γ-aminobutyric acid, glutamate, and serotonin, as well as systems modulating the brain's stress response. These neuroadaptations produce changes in sensitivity to alcohol's effects following repeated exposure (i.e., sensitization and tolerance) and a withdrawal state following discontinuation of alcohol use. Chronic alcohol exposure also results in persistent neural deficits, some of which may fully recover following extended periods of abstinence. However, the organism remains susceptible to relapse, even after long periods of abstinence. Recent research focusing on brain arousal, reward, and stress systems is accelerating our understanding of the components of alcohol dependence and contributing to the development of new treatment strategies.

Similar Articles

Drug harms in the UK: a multicriteria decision analysis

Author(s): Nutt DJ, King LA, Phillips LD

Pharmacological management of alcohol dependence: from mono-therapy to pharmacogenetics and beyond

Author(s): Caputo F, Vignoli T, Grignaschi A, Cibin M, Addolorato G, et al.

Neurocircuitry of addiction

Author(s): Koob GF, Volkow ND

Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses

Author(s): Leone MA, Vigna-Taglianti F, Avanzi G, Brambilla R, Faggiano

Understanding opioid reward

Author(s): Fields HL, Margolis EB

Central effects of acamprosate: part 1

Author(s): Dahchour A, De Witte P, Bolo N, Nédélec JF, Muzet M, et al.

Alcoholism is a disinhibitory disorder: neurophysiological evidence from a Go/No-Go task

Author(s): Kamarajan C, Porjesz B, Jones KA, Choi K, Chorlian DB, et al.

Microglia in neurodegenerative disease

Author(s): Perry VH, Nicoll JA, Holmes C